Vical Inc (NASDAQ:VICL)

1.02
Delayed Data
As of Feb 27
 +0.01 / +0.99%
Today’s Change
0.89
Today|||52-Week Range
1.60
-2.86%
Year-to-Date
Frontrunning: February 26
Feb 26 / Investing Channel
 

Today’s Trading

Previous close1.01
Today’s open1.01
Day’s range1.00 - 1.03
Volume309,804
Average volume (3 months)417,367
Market cap$92.2M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+49.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.94%
P/E ratioNM
Price/Sales13.28
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.38+5.54%
EVARLombard Medical Inc-0.27-4.56%
NEOTNeothetics Inc-0.05-0.74%
BLRXBioLine RX Ltd+0.03+1.30%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$7.7M
Annual profit (last year)-$31.2M
Net profit margin-404.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account